Influenza vaccine-induced interstitial lung disease

Watanabe Satoshi, Waseda Yuko, Takato Hazuki, Inuzuka Kanako, Katayama Nobuyuki, Kasahara Kazuo, Fujimura Masaki

Source: Eur Respir J 2013; 41: 474-477
Journal Issue: February

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Watanabe Satoshi, Waseda Yuko, Takato Hazuki, Inuzuka Kanako, Katayama Nobuyuki, Kasahara Kazuo, Fujimura Masaki. Influenza vaccine-induced interstitial lung disease. Eur Respir J 2013; 41: 474-477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Influenza vaccine-induced ILD
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

Influenza and co-infections of the lung
Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care
Year: 2014

Humoral immunodeficiency and the lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220
Year: 2005

Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Autoantibodies in interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Source: Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021
Year: 2021

Pulmonary diseases in primary immunodeficiency syndromes
Source: Respipedia Article
Year: 2017

HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010

Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019

Humoral immune response to influenza vaccination in silicosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 695s
Year: 2006

Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005

Interstitial lung disease in common variable immunodeficiency associated granulomatous disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009

Severe influenza virus H1N1: Lung pathology
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010